BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 18, 1999
View Archived Issues
CLASS study evaluates clomethiazole in acute stroke patients
Read More
Teijin in-licenses novel asthma therapeutic from Byk Gulden
Read More
SmithKline Beecham describes novel compounds for depression and other CNS disorders
Read More
Eradication of H. pylori has dubious therapeutic effect in patients with nonulcer dyspepsia
Read More
Selective dopamine D3 receptor modulators synthesized at SB
Read More
Takeda develops compounds that induce and/or enhance cell differentiation
Read More
Research at Jouveinal leads to potent and selective PDE4 inhibitors
Read More
More PDE5 inhibitors in the Pfizer pipeline
Read More
Novel antidiabetic agents in development at Novo Nordisk
Read More
CPMP approves angiotensin II antagonist for management of hypertension
Read More
Cortex licenses Ampakine rights to Organon
Read More
Orphan drug for iron overload offered for licensing by Biomedical Frontiers
Read More
FDA approves Pletal for intermittent claudication
Read More
Warner-Lambert updates U.S. status of Rezulin
Read More
MIST study provides further evidency of zanamivir's efficacy and safety
Read More
Epitope-based HIV vaccines show promise according to results from studies in primates
Read More
Novartis initiates phase III trial of schizophrenia treatment
Read More
XTL's first fully human MAb heading for clinical trials this quarter
Read More
Greater antitumor efficacy and less toxicity obtained with liposomal cisplatin
Read More
Beraprost to enter clinical trials in North America
Read More
Milestone reached by Cadus in drug discovery collaboration with SmithKline Beecham
Read More
Biogen: Q4 and FY 1998 highlights
Read More
Tenth HuMAb-Mouse licensing agreement for Medarex: Immunex granted broad rights
Read More
Palatin and Nihon Medi-Physics intend to develop radiopharmaceutical products
Read More
Antitumor candidate originating in Kazakstan slated for development in U.S. and other countries
Read More